WASHINGTON TRUST Co Boosts Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

WASHINGTON TRUST Co boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 23.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,293 shares of the company’s stock after buying an additional 440 shares during the quarter. WASHINGTON TRUST Co’s holdings in GE HealthCare Technologies were worth $179,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Sequoia Financial Advisors LLC grew its stake in shares of GE HealthCare Technologies by 1.9% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 9,276 shares of the company’s stock worth $723,000 after purchasing an additional 174 shares during the period. Delta Financial Group Inc. grew its stake in shares of GE HealthCare Technologies by 2.6% during the 2nd quarter. Delta Financial Group Inc. now owns 8,272 shares of the company’s stock worth $645,000 after purchasing an additional 207 shares during the period. Bridge Creek Capital Management LLC grew its stake in GE HealthCare Technologies by 3.9% in the 2nd quarter. Bridge Creek Capital Management LLC now owns 10,445 shares of the company’s stock valued at $814,000 after acquiring an additional 394 shares during the period. Granite Bay Wealth Management LLC acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at $534,000. Finally, Artemis Investment Management LLP grew its stake in GE HealthCare Technologies by 8.3% in the 2nd quarter. Artemis Investment Management LLP now owns 121,313 shares of the company’s stock valued at $9,453,000 after acquiring an additional 9,309 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Mizuho dropped their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, May 1st. The Goldman Sachs Group assumed coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price target on the stock. Stifel Nicolaus assumed coverage on shares of GE HealthCare Technologies in a research note on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target on the stock. Bank of America dropped their price target on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Finally, Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Five investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $94.58.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CEO Jan Makela sold 66,955 shares of the business’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total value of $5,459,510.70. Following the sale, the chief executive officer now directly owns 63,348 shares in the company, valued at approximately $5,165,395.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The disclosure for this sale can be found here. Insiders have sold a total of 73,005 shares of company stock worth $5,941,366 in the last quarter. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Up 2.3 %

Shares of NASDAQ GEHC traded up $1.93 during trading on Tuesday, hitting $84.30. 821,190 shares of the company were exchanged, compared to its average volume of 3,088,571. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.83 and a current ratio of 1.06. The company has a fifty day moving average price of $79.30 and a 200-day moving average price of $82.85. The firm has a market capitalization of $38.48 billion, a PE ratio of 24.08, a P/E/G ratio of 3.00 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same quarter in the previous year, the firm earned $0.92 EPS. The company’s quarterly revenue was up .5% compared to the same quarter last year. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be issued a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.